Clinical Trials on Maladie d'Alzheimer de type 2

Total 9607 results

PETHEMA Foundation

Recruiting

Clinical Trial to Assess the Safety and Tolerability of the Combination of Low-dose Cytarabine or Azacitidine Plus Venetoclax and Quizartinib in Newly Diagnosed AML Patients Aged Equal or More Than 60 Years Old

Leukemia, Myeloid, Acute | De Novo | Age More 60yr

Spain
Mathias Ried-Larsen

Completed

Exercise Volume and Beta-cell Function in T2D The DOSE-EX Randomized Trial (DOSE-EX)

Diabetes Mellitus, Type 2 | Type 2 Diabetes Mellitus | Type2 Diabetes | Type2 Diabetes Mellitus

Denmark
National Taiwan Normal University

Completed

Acute Exercise on Neurocognitive Function Among Adults With/Without Generic Risk of AD

Alzheimer Disease 2 Due to Apoe4 Isoform

Taiwan
Karolinska Institutet
University of Dschang

Recruiting

Association of Diabetes and Metabolic Syndrome With Severe Malaria in Cameroon

Obesity | Diabetes Mellitus, Type 2 | Metabolic Syndrome | Malaria,Falciparum | Severe Malaria

Cameroon
Northern Care Alliance NHS Foundation Trust
Brighter AB

Completed

Actiste® Diabetes Management as a Service (ADMS) Clinical Investigation (ADMSUK01)

Diabetes type1 | Diabetes type2

United Kingdom
University of Kansas Medical Center
National Institute on Aging (NIA)

Completed

Dementia Risk and Dynamic Response to Exercise (DYNAMIC)

Healthy Aging | Alzheimer Disease 2 Due to Apoe4 Isoform

United States
Hospital Universitari Vall d'Hebron Research Institute

Completed

Type 2 Diabetes Mellitus as Catalyst for Alzheimer's Disease (DIACEA)

Diabetes Mellitus Type 2 | Alzheimer´s Disease

Spain
Hanmi Pharmaceutical Company Limited

Unknown

Multiple Ascending Dose Study of HM12470 in Type 1 and Type 2 Diabetes Mellitus

Type2 Diabetes Mellitus | Type1 Diabetes Mellitus

United States
Eli Lilly and Company

Active, not recruiting

A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both (SURPASS-PEDS)

Glucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | Type2 Diabetes | Metabolic Disease | T2DM (Type 2 Diabetes Mellitus) | T2D

United States, India, Australia, United Kingdom, Mexico, Brazil, Israel, France, Italy
Chinese University of Hong Kong

Completed

Randomised Placebo-controlled Study of FMT to Impact Body Weight and Glycemic Control in Obese Subjects With T2DM

Type 2 Diabetes Mellitus | Type2 Diabetes | Obese

Hong Kong
Centre Hospitalier Universitaire Dijon

Completed

Influence of Glycaemic Balance on the Ability of Apolipoprotein C1 to Inhibit Cholesteryl Ester Transfer Protein in Type-1 Diabetes Patients (ApoC1)

diabète de Type 1

France
Leiden University Medical Center
Andaluz Health Service

Completed

"POWER2DM Evaluation Campaign" (POWER2DMEC)

Diabetes Mellitus | Health Behavior | Self Efficacy | Type2 Diabetes Mellitus | Type1 Diabetes Mellitus

Netherlands, Spain
Hospital Universitari Vall d'Hebron Research Institute

Completed

Retinal Neurodegeneration in Type 2 Diabetes as Biomarker for Alzheimer´s Disease (DIALRET)

Type 2 Diabetes | Alzheimer´s Disease | Retinal Neurodegeneration

Spain
Aphios

Not yet recruiting

Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease

Dementia | Alzheimer Disease 1 | Alzheimer Disease 2 | Alzheimer Disease 3
Yanbing Li

Recruiting

Effects of Short-term Intensive De-escalation Therapy on Long-term Regimen Simplification (ESTIMATOR)

Diabetes type2

China
Mondelēz International, Inc.
Centre de Recherche en Nutrition Humaine Rhone-Alpe; Biofortis Mérieux NutriSciences

Recruiting

Cardio-metabolic and Inflammatory Impact of Starch Digestibility in Type 2 Diabetic Patients

Type2 Diabetes

France
Penn State University

Completed

Almond Butter and Fasting Glucose

Type2 Diabetes

United States
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin

Type2 Diabetes

Korea, Republic of
Faculty of Medical Sciences, Clinical Hospital

Completed

Effects of Yogurt With Probiotics in Adults With Type 2 Diabetes Mellitus

Type2 Diabetes

Spain
Savvysherpa, Inc.

Completed

Continuous Glucose Monitors to Regulate Glucose Levels in Type 2 Diabetics - (Protocol 3) (CGM_IRB-3)

Type2 Diabetes

United States
Tel-Aviv Sourasky Medical Center

Unknown

16-week Flexible vs. 8-week Semaglutide Titration

Diabetes type2

Israel
Mondelēz International, Inc.
Centre de Recherche en Nutrition Humaine Rhone-Alpe; Biofortis Mérieux NutriSciences

Completed

Evaluation of 2 Diets With Different Starch Digestibility Profiles on Daily Glycemic Profile, in T2D Patients

Type2 Diabetes

France
Centro de Estudios en Alimentación y Nutrición,...

Completed

Oat Beta-glucan as a Supplement in Chilean Type 2 Diabetics

Type2 Diabetes

Chile
ALI KAMAL M. SAMI

Completed

Using Nanotechnology Structured Water to Control Blood Glucose in Type 2 Diabetic Patients.

Type2 Diabetes
AJU Pharm Co., Ltd.

Completed

Efficacy and Safety of AJU-A51 in Type 2 Diabetes Mellitus Patients

Type2 Diabetes

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of D745, D759, and D150

Diabetes type2

Korea, Republic of
National University of Singapore

Completed

Collaborative Care Model on Type 2 Diabetic Patients

Type2 Diabetes

Singapore
Weill Cornell Medical College in Qatar
Novo Nordisk A/S

Terminated

Randomised Open Label Study of Insulin Degludec Versus Insulin Glargine U100 in Ramadan

Type2 Diabetes

Qatar
Hospices Civils de Lyon

Completed

Triglyceride Rich Lipoproteins and Platelet Activation in Type 2 Diabetes (COMPLETE)

Type2 Diabetes

France
Nanjing First Hospital, Nanjing Medical University

Unknown

Effects of Replacing Lantus With Basalin on the Glycemic Variation in Patients With Type 2 Diabetes Mellitus

Type2 Diabetes

China
Savvysherpa, Inc.

Completed

Continuous Glucose Monitors to Regulate Glucose Levels in Type 2 Diabetics (CGM_IRB2)

Type2 Diabetes

United States
VitNovo, Inc.

Completed

DCB-DM101 in Healthy Volunteers and for Type 2 Diabetes Mellitus Patients

Type2 Diabetes

Taiwan
Qianfoshan Hospital

Completed

Remission Rate of Newly Diagnosed Type 2 Diabetes Outpatients Treated With Short-term Intensive Insulin Therapy

Type2 Diabetes

China
Yale University
Juvenile Diabetes Research Foundation

Terminated

Pathogenesis of the Cardiometabolic Risk in Youth With Type 1 Diabetes

Type 1 Diabetes | De Novo Lipogenesis

United States
Insulet Corporation
Jaeb Center for Health Research

Completed

OP5-005 Using Omnipod 5 in Adults With Type 2 (SECURE-T2D)

Type2 Diabetes

United States
Clinical Research Centre, Malaysia
Ministry of Health, Malaysia

Completed

Effectiveness of PICC Improving HBA1C and Knowledge in Diabetes Mellitus Education (EPICCIHKDMEP)

Diabetes Mellitus | Type2 Diabetes

Malaysia
Chungbuk National University Hospital

Completed

Head-to-head Comparison of Empagliflozin and Dapagliflozin

Type2 Diabetes

Korea, Republic of
ValoTec
APHP

Terminated

Data Acquisition Study in Inadequately Balanced Patients With Type 2 Diabetes Mellitus

Type2 Diabetes

France
Chong Kun Dang Pharmaceutical

Completed

Retrospective Study to Evaluate the Safety of Duvie in Korean Patients With Type 2 Diabetes Mellitus (DISCOVERY)

Type2 Diabetes

Korea, Republic of
National Taipei University of Nursing and Health...
Chiayi Christian Hospital

Completed

Effects of the Insulin Self Titration Education for Type 2 Diabetes Mellitus Patients (ISTE)

Type2 Diabetes
Istanbul Medeniyet University

Completed

The Effect of Fasting on Serum Osmolarity in Diabetic Patients

Type2 Diabetes

Turkey
Arizona State University

Completed

An Alternative Approach to Improve Hyperglycemia Among Type 2 Diabetes Patients

Type2 Diabetes
Cognito Therapeutics, Inc.

Recruiting

A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (Hope Study, CA-0011) (Hope)

Cognitive Impairment | Dementia | Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | MCI | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Cognitive Impairment, Mild | Alzheimer Disease 1 | Dementia, Mild | Alzheimer... and other conditions

United States
Azienda Provinciale per i Servizi Sanitari, Provincia...
Ministero della Salute, Italy; Fondazione Bruno Kessler; Provincia Autonoma di... and other collaborators

Recruiting

Organisational Models Supported by Technology for the Management of Diabetic Disease and Its Complications in a Diabetic Clinic Setting. A Randomised Controlled Trial Targeting Type 2 Diabetes Individuals With Non-ideal Glycemic Values (Telemechron)

Diabetes type2

Italy
The Deutsche Diabetes Forschungsgesellschaft e.V.
Algiax Pharmaceuticals GmbH

Recruiting

Effects of GABAA Receptor Modulation by AP-325 on Insulin Secretion in Patients With Type 2 Diabetes

Type2 Diabetes

Germany
GCS Ramsay Santé pour l'Enseignement et la Recherche

Not yet recruiting

Personalized Follow-up Program in the Type 2 Diabetes Prevention (PROXIPART)

Type2 Diabetes
Charite University, Berlin, Germany
University Hospital Tuebingen; Technische Universität Berlin; German Institute...

Recruiting

Whey or Casein - Liver Fat Reduction and Metabolic Improvement by Fast vs. Slow Proteins (MOCA)

NAFLD | Type2 Diabetes

Germany
Royal College of Surgeons in Ireland - Medical...
King Hamad University Hospital, Bahrain

Completed

Date Fruit Effects in Type 2 Diabetes

Type2 Diabetes

Bahrain
Aboca Spa Societa' Agricola
Latis S.r.l.; Fondazione Edmund Mach

Completed

ABO-GLYC in Type 2 Diabetes

Type2 Diabetes

Italy
Theracos

Completed

Safety and Efficacy of Bexagliflozin Compared to Placebo as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

Type2 Diabetes Mellitus

United States, Japan

Clinical Trials on Maladie d'Alzheimer de type 2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations